IBDEI2XP ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46827,1,3,0)
 ;;=3^Sex dysfxn not d/t subst/knwn physlg cond,Oth
 ;;^UTILITY(U,$J,358.3,46827,1,4,0)
 ;;=4^F52.8
 ;;^UTILITY(U,$J,358.3,46827,2)
 ;;=^5003624
 ;;^UTILITY(U,$J,358.3,46828,0)
 ;;=F52.22^^179^2336^1
 ;;^UTILITY(U,$J,358.3,46828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46828,1,3,0)
 ;;=3^Female sexual arousal disorder
 ;;^UTILITY(U,$J,358.3,46828,1,4,0)
 ;;=4^F52.22
 ;;^UTILITY(U,$J,358.3,46828,2)
 ;;=^5003621
 ;;^UTILITY(U,$J,358.3,46829,0)
 ;;=F52.21^^179^2336^2
 ;;^UTILITY(U,$J,358.3,46829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46829,1,3,0)
 ;;=3^Male erectile disorder
 ;;^UTILITY(U,$J,358.3,46829,1,4,0)
 ;;=4^F52.21
 ;;^UTILITY(U,$J,358.3,46829,2)
 ;;=^5003620
 ;;^UTILITY(U,$J,358.3,46830,0)
 ;;=N47.2^^179^2337^17
 ;;^UTILITY(U,$J,358.3,46830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46830,1,3,0)
 ;;=3^Paraphimosis
 ;;^UTILITY(U,$J,358.3,46830,1,4,0)
 ;;=4^N47.2
 ;;^UTILITY(U,$J,358.3,46830,2)
 ;;=^90023
 ;;^UTILITY(U,$J,358.3,46831,0)
 ;;=N47.1^^179^2337^19
 ;;^UTILITY(U,$J,358.3,46831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46831,1,3,0)
 ;;=3^Phimosis
 ;;^UTILITY(U,$J,358.3,46831,1,4,0)
 ;;=4^N47.1
 ;;^UTILITY(U,$J,358.3,46831,2)
 ;;=^93340
 ;;^UTILITY(U,$J,358.3,46832,0)
 ;;=N47.5^^179^2337^1
 ;;^UTILITY(U,$J,358.3,46832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46832,1,3,0)
 ;;=3^Adhesions prepuce/glans penis
 ;;^UTILITY(U,$J,358.3,46832,1,4,0)
 ;;=4^N47.5
 ;;^UTILITY(U,$J,358.3,46832,2)
 ;;=^5015728
 ;;^UTILITY(U,$J,358.3,46833,0)
 ;;=N47.4^^179^2337^4
 ;;^UTILITY(U,$J,358.3,46833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46833,1,3,0)
 ;;=3^Benign cyst prepuce
 ;;^UTILITY(U,$J,358.3,46833,1,4,0)
 ;;=4^N47.4
 ;;^UTILITY(U,$J,358.3,46833,2)
 ;;=^5015727
 ;;^UTILITY(U,$J,358.3,46834,0)
 ;;=N47.8^^179^2337^21
 ;;^UTILITY(U,$J,358.3,46834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46834,1,3,0)
 ;;=3^Prepuce disorders,other
 ;;^UTILITY(U,$J,358.3,46834,1,4,0)
 ;;=4^N47.8
 ;;^UTILITY(U,$J,358.3,46834,2)
 ;;=^5015730
 ;;^UTILITY(U,$J,358.3,46835,0)
 ;;=N47.7^^179^2337^22
 ;;^UTILITY(U,$J,358.3,46835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46835,1,3,0)
 ;;=3^Prepuce inflammatory diseases,Other
 ;;^UTILITY(U,$J,358.3,46835,1,4,0)
 ;;=4^N47.7
 ;;^UTILITY(U,$J,358.3,46835,2)
 ;;=^5015729
 ;;^UTILITY(U,$J,358.3,46836,0)
 ;;=N48.1^^179^2337^2
 ;;^UTILITY(U,$J,358.3,46836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46836,1,3,0)
 ;;=3^Balanitis
 ;;^UTILITY(U,$J,358.3,46836,1,4,0)
 ;;=4^N48.1
 ;;^UTILITY(U,$J,358.3,46836,2)
 ;;=^12525
 ;;^UTILITY(U,$J,358.3,46837,0)
 ;;=N47.6^^179^2337^3
 ;;^UTILITY(U,$J,358.3,46837,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46837,1,3,0)
 ;;=3^Balanoposthitis
 ;;^UTILITY(U,$J,358.3,46837,1,4,0)
 ;;=4^N47.6
 ;;^UTILITY(U,$J,358.3,46837,2)
 ;;=^12530
 ;;^UTILITY(U,$J,358.3,46838,0)
 ;;=N48.30^^179^2337^25
 ;;^UTILITY(U,$J,358.3,46838,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46838,1,3,0)
 ;;=3^Priapism, Unspec
 ;;^UTILITY(U,$J,358.3,46838,1,4,0)
 ;;=4^N48.30
 ;;^UTILITY(U,$J,358.3,46838,2)
 ;;=^5015733
 ;;^UTILITY(U,$J,358.3,46839,0)
 ;;=N48.32^^179^2337^23
 ;;^UTILITY(U,$J,358.3,46839,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46839,1,3,0)
 ;;=3^Priapism d/t disease classified elsewhere
 ;;^UTILITY(U,$J,358.3,46839,1,4,0)
 ;;=4^N48.32
 ;;^UTILITY(U,$J,358.3,46839,2)
 ;;=^5015735
